These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8736724)

  • 41. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
    Belsey EM; d'Arcangues C; Carlson N
    Contraception; 1988 Aug; 38(2):243-57. PubMed ID: 2971508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent experience with and future directions of contraceptive implants and injectable contraceptives.
    Alvarez-Sanchez F; Brache V; Faundes A
    Curr Opin Obstet Gynecol; 1993 Dec; 5(6):805-14. PubMed ID: 8286694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Existing once-a-month combined injectable contraceptives.
    Toppozada MK
    Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Historical survey of modern reversible contraceptive methods].
    Mbabajende V
    Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
    Coukell AJ; Balfour JA
    Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical relevance in present day hormonal contraception.
    Regidor PA
    Horm Mol Biol Clin Investig; 2018 Oct; 37(1):. PubMed ID: 30367791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New advances in contraception and sterilization].
    Iglesias Cortit L
    Med Clin (Barc); 1985 Nov; 85(14):588-95. PubMed ID: 3908850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contraceptive introduction and the management of choice: the role of Cyclofem in Indonesia.
    Simmons R; Fajans P; Lubis F
    Contraception; 1994 May; 49(5):509-25. PubMed ID: 8045135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
    Landgren BM; Hall PE; Cekan SZ
    Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contraceptive implants.
    Ladipo O; Coutinho EM
    Curr Opin Obstet Gynecol; 1994 Dec; 6(6):564-9. PubMed ID: 7893965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New concepts in contraception: Norplant subdermal implant.
    Lynn MM; Holdcroft C
    Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subdermal contraceptive implants in nurse-midwifery practice.
    Emerling JM; Paluzzi P; Leiva J; Cullins VE
    J Nurse Midwifery; 1993; 38(2 Suppl):80S-87S. PubMed ID: 8483013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
    el Nahal N; Hassan EO; el Houssinie M
    Contraception; 1999 Jun; 59(6):369-75. PubMed ID: 10518231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.